US Stock Market Movement | Medical technology company Davion Healthcare Plc (DAVI.US) debuts on the US stock market; shares fall over 12% after opening

智通财经APP reported that on Thursday, Davion Healthcare Plc (DAVI.US) was listed on the US stock market, with its share price falling by more than 12% after opening, quoted at $10.73. The IPO price was $12.25. Davion Healthcare Plc is a medical technology company headquartered in Ireland, focusing on the development and commercialization of non-invasive home health monitoring technologies aimed at helping consumers detect potential health abnormalities early. The company's flagship product, BreastCheck, is a home breast health screening device registered with the US Food and Drug Administration (FDA). It can identify potential abnormalities by monitoring temperature changes on the breast surface, with the detection process taking less than 15 minutes. Results can be viewed via a mobile application or online, but it cannot replace mammography or clinical diagnosis.